Leigh Marcus
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
- CAR-T cell therapy research
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
Papers in
- Oncology 8
- Cancer Immunotherapy and Biomarkers 4
- Cancer Treatment and Pharmacology 3
- Colorectal Cancer Treatments and Studies 2
-
- Genetic factors in colorectal cancer 3
- Co-authors
- Richard Pazdur (7 shared papers)Steven J. Lemery (6 shared papers)Patricia Keegan (3 shared papers)Lola A. Fashoyin‐Aje (4 shared papers)Martha Donoghue (3 shared papers)Marc R. Theoret (4 shared papers)Reena Philip (1 shared paper)Pamela Gallagher (1 shared paper)
- Journals
- Clinical Cancer Research (7 papers)Pediatric Blood & Cancer (2 papers)Journal of Clinical Oncology (1 paper)Blood (1 paper)Clinical Pharmacology & Therapeutics (1 paper)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
Leigh Marcus
17 papers receiving 1.6k citations
Leigh Marcus's Hit Papers
Peers
Comparison fields: 5 of 79
- Oncology 1.1k
- Cancer Research 457
- Pathology and Forensic Medicine 358
- Pulmonary and Respiratory Medicine 488
- Immunology 217
Countries citing papers authored by Leigh Marcus
This map shows the geographic impact of Leigh Marcus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leigh Marcus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leigh Marcus more than expected).
Fields of papers citing papers by Leigh Marcus
This network shows the impact of papers produced by Leigh Marcus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leigh Marcus. The network helps show where Leigh Marcus may publish in the future.
Co-authors
The 25 scholars most cited alongside Leigh Marcus, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | FDA Approval Summary: Pembrolizumab for the Treatment of Microsatellite Instability-High Solid Tumors Hit paper breakdown → | 2019 | 789 |
| 2 | FDA Approval Summary: Pembrolizumab for the Treatment of Tumor Mutational Burden–High Solid Tumors Hit paper breakdown → | 2021 | 330 |
| 3 | 2021 | 119 | |
| 4 | 2013 | 110 | |
| 5 | 2020 | 92 | |
| 6 | 2014 | 37 | |
| 7 | 2017 | 35 | |
| 8 | 2022 | 33 | |
| 9 | 2014 | 30 | |
| 10 | 2017 | 17 | |
| 11 | 2015 | 15 | |
| 12 | 2014 | 13 | |
| 13 | 2011 | 10 | |
| 14 | 2015 | 8 | |
| 15 | 2022 | 5 | |
| 16 | 2011 | 4 | |
| 17 | 2015 | 2 | |
| 18 | 2025 | 0 |
About Leigh Marcus
Leigh Marcus is a scholar working on Oncology, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Epidemiology and Surgery, having authored 18 papers that have together received 1.6k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (5 papers), Cancer Immunotherapy and Biomarkers (4 papers), Cancer Treatment and Pharmacology (3 papers), Genetic factors in colorectal cancer (3 papers), Cancer Genomics and Diagnostics (3 papers), Lung Cancer Treatments and Mutations (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers) and Colorectal Cancer Treatments and Studies (2 papers). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (457 citations), Pathology and Forensic Medicine (358 citations), Pulmonary and Respiratory Medicine (488 citations) and Immunology (217 citations). Leigh Marcus has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Richard Pazdur, Steven J. Lemery, Patricia Keegan, Lola A. Fashoyin‐Aje, Martha Donoghue, Marc R. Theoret, Reena Philip, Pamela Gallagher, Soma Ghosh and Julia A. Beaver. Their work appears in journals such as Clinical Cancer Research, Pediatric Blood & Cancer, Journal of Clinical Oncology, Blood and Clinical Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.